Atmos Energy Corporation · ATO · FY2026 Q2 · Calendar Q2 2026

Atmos Energy Beats Estimates, Raises EPS Guidance on Texas Rule Benefit and Customer Growth

Atmos Energy delivered a modest EPS and revenue beat for FY2026 Q2, supported by strong customer growth in Texas and a favorable regulatory tailwind from Texas Rule 7.7102. Management raised full-year EPS guidance to $8.40–$8.50, citing $155–$165 million in pretax benefits from the rule change and robust through-system earnings from the APT pipeline segment. Despite the raised outlook, the stock traded below the benchmark in the immediate reaction window and drifted roughly 6% lower over subsequent weeks, suggesting the market is weighing regulatory execution risk, commodity-price sensitivity at the Waha hub, and elevated capital spending against the guidance increase.

Reported After market closeNYSEUtilities $29.66B market cap
90quality score

Company context

Snapshot as of publication

Atmos Energy Corporation, alongside its subsidiaries, is a U.S.-based enterprise primarily involved in the regulated distribution of natural gas, as well as operating pipeline and storage facilities. The company functions through two core divisions: Distribution, and Pipeline and Storage. The Distribution division manages the regulated delivery and associated sales of natural gas across eight states. This division supplies natural gas to approximately three million customers, encompassing homeowners, businesses, public agencies, and industrial clients.…

Earnings scorecard

Reported versus consensus
Reported EPS $3.47 Consensus $3
EPS surprise +1.8% Reported versus consensus
Reported revenue $1.96B Consensus $1.94B
Revenue surprise +1.1% Reported versus consensus

Earnings History

Estimate Beat Miss Match
ATO EPS earnings history estimate and actual scatter chart 8 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $2.05 Q1 '24 actual $2.08, beat Q2 '24 estimate $2.61 Q2 '24 actual $2.85, beat Q3 '24 estimate $1.05 Q3 '24 actual $1.08, beat Q4 '24 estimate $0.80 Q4 '24 actual $0.86, beat Q3 '25 estimate $1.14 Q3 '25 actual $1.16, beat Q4 '25 estimate $0.99 Q4 '25 actual $1.07, beat Q1 '26 estimate $2.44 Q1 '26 actual $2.44, match Q2 '26 estimate $3.41 Q2 '26 actual $3.47, beat Q3 '26 estimate $1.34 Q4 '26 estimate $1.21 Q1 '27 estimate $2.62 Q2 '27 estimate $3.69

Analyst Consensus ?

ConsensusHold21 ratings
Bullish942.9%
Neutral1257.1%
Bearish00.0%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$175.69Current
$113Low
$164.36Average
$200High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Truist Securities Hold HoldMaintainJul 17, 2026
JP Morgan Overweight OverweightMaintainJul 14, 2026
Barclays Equal Weight Equal WeightMaintainJul 14, 2026
Argus Research Buy BuyMaintainJul 2, 2026
Mizuho Neutral NeutralMaintainMay 29, 2026
TD Cowen Hold HoldMaintainMay 15, 2026
Citigroup Neutral NeutralMaintainMay 8, 2026
Morgan Stanley Equal Weight Equal WeightMaintainApr 21, 2026
UBS Neutral NeutralMaintainDec 17, 2025
B of A Securities Neutral BuyDowngradeOct 16, 2025
Ladenburg Thalmann Neutral BuyDowngradeAug 8, 2025
Wells Fargo Overweight OverweightMaintainOct 16, 2024
Credit Suisse Outperform OutperformMaintainNov 14, 2022
Goldman Sachs Neutral BuyDowngradeMay 13, 2022
Seaport Global Neutral BuyDowngradeApr 7, 2021
Bank of America Buy NeutralUpgradeJan 7, 2020
Argus Buy HoldUpgradeMay 5, 2018
BB&T Capital Buy BuyMaintainMar 30, 2016
Edward Jones Buy HoldUpgradeAug 8, 2014
U.S. Capital Advisors Hold UnderweightUpgradeMar 19, 2014
Hilliard Lyons Long Term Buy Long Term BuyMaintainAug 10, 2012
Bank oferica Buy BuyMaintainMay 17, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $175.69. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Morgan StanleyAnalyst unavailable$196$176.52 +11.6%Jul 22, 2026
BarclaysAnalyst unavailable$183$179.5 +4.2%Jul 14, 2026
Wells FargoConstantine Lednev$200$176.2 +13.8%Jul 13, 2026
Argus ResearchMarie Ferguson$185$174.76 +5.3%Jul 2, 2026
Morgan StanleyAnalyst unavailable$190$172.4 +8.1%Jun 24, 2026
Mizuho SecuritiesGabriel Moreen$184$173.01 +4.7%May 29, 2026
Morgan StanleyAnalyst unavailable$183$175.58 +4.2%May 21, 2026
Truist FinancialAnalyst unavailable$187$176.48 +6.4%May 18, 2026
Morgan StanleyAnalyst unavailable$195$184.19 +11.0%Apr 21, 2026
Morgan StanleyAnalyst unavailable$192$180.38 +9.3%Feb 20, 2026
BarclaysAnalyst unavailable$167$168.5 -4.9%Jan 27, 2026
Morgan StanleyAnalyst unavailable$180$167.87 +2.5%Jan 21, 2026
BarclaysAnalyst unavailable$165$168.72 -6.1%Jan 15, 2026
UBSAnalyst unavailable$174$168 -1.0%Dec 17, 2025
Morgan StanleyAnalyst unavailable$172$170.77 -2.1%Dec 16, 2025
Mizuho SecuritiesGabriel Moreen$180$171.72 +2.5%Dec 2, 2025
Morgan StanleyAnalyst unavailable$182$174.87 +3.6%Nov 20, 2025
Morgan StanleyDavid Arcaro$181$177.54 +3.0%Oct 22, 2025
BarclaysAnalyst unavailable$172$174.93 -2.1%Oct 9, 2025
BarclaysAnalyst unavailable$175$175.75 -0.4%Oct 9, 2025
Mizuho SecuritiesAnalyst unavailable$170$169.23 -3.2%Sep 26, 2025
Morgan StanleyAnalyst unavailable$167$166.46 -4.9%Sep 25, 2025
Argus ResearchMarie Ferguson$172$161.82 -2.1%Sep 18, 2025
UBSAnalyst unavailable$159$156.2 -9.5%Jul 30, 2025
Morgan StanleyDavid Arcaro$156$152.39 -11.2%Jun 18, 2025
Wells FargoSarah Akers$156$142 -11.2%Oct 16, 2024
Mizuho SecuritiesGabriel Moreen$148$136.48 -15.8%Sep 25, 2024
Wells FargoSarah Akers$132$116.84 -24.9%May 14, 2024
Mizuho SecuritiesGabriel Moreen$138$116.77 -21.5%May 13, 2024
UBSWilliam Appicelli$124$114.38 -29.4%Apr 12, 2024
Mizuho SecuritiesGabriel Moreen$131$111.6 -25.4%Oct 11, 2023
J.P. MorganAnalyst unavailable$115$112.39 -34.5%Jan 9, 2023
Morgan StanleyAnalyst unavailable$128$116.6 -27.1%Dec 15, 2022
Morgan StanleyAnalyst unavailable$120$111.54 -31.7%Nov 11, 2022
BarclaysAnalyst unavailable$115$111.9 -34.5%Jul 18, 2022
Goldman SachsInsoo Kim$113$112.09 -35.7%May 12, 2022
Mizuho SecuritiesAnalyst unavailable$131$114.58 -25.4%Apr 29, 2022
Morgan StanleyAnalyst unavailable$140$118 -20.3%Apr 26, 2022
Credit SuisseAnalyst unavailable$133$117.7 -24.3%Apr 26, 2022
Morgan StanleyAnalyst unavailable$139$122.28 -20.9%Apr 20, 2022
Show less

Track every rating change on ATO the moment it posts. Free to start.

Start free

Market reaction

event-close to next-session close
Stock move -1.6% Event window
SPY move -0.3% Same window
Abnormal move -1.3% Stock minus SPY
Volume 2.4× Versus trailing sessions
Subsequent drift -6.4% Up to 20 sessions
ATOSPY benchmark

Follow ATO with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

Atmos reported FY26 first-half net income of $985 million, with Q2 EPS of $3.47 beating the $3.41 consensus by 1.8% and revenue of $1.96 billion exceeding the $1.94 billion estimate by 1.1%. The company added over 51,000 customers in the past year, including 39,000+ in Texas. Texas House Bill 4384 contributed $94 million to H1 earnings. The final rulemaking of Texas Rule 7.7102 reclassifies post-service carrying costs and adds a $155–$165 million pretax benefit for FY26 without affecting net earnings. The dividend was increased approximately 15% year-over-year, reflecting both a rebasing of earnings and the regulatory impact. Capex reached $2 billion in H1 and remains on track for $4.2 billion in FY26.

Guidance delta

Full-year EPS guidance raised to $8.40–$8.50 from the prior outlook, reflecting higher APT through-system earnings, the Rule 7.7102 pretax benefit, and continued customer growth. Management targets an additional $0.08–$0.12 contribution from APT through-system business in H2 FY26 and expects roughly 40% of the $600 million in annualized operating-income increases from 13 pending regulatory filings to be realized in Q3.

Key takeaways

  • Q2 EPS of $3.47 beat the $3.41 consensus by 1.8%; revenue of $1.96 billion exceeded the $1.94 billion estimate by 1.1%.
  • Full-year EPS guidance raised to $8.40–$8.50 on the back of Texas Rule 7.7102 ($155–$165 million pretax benefit) and stronger APT through-system earnings.
  • Customer base grew by over 51,000 in the past year, with 39,000+ additions in Texas alone.
  • Capital spending reached $2 billion in H1 and remains on track for $4.2 billion in FY26, focused on safety, reliability, and system expansion.
  • Dividend increased approximately 15% year-over-year, with management committing to incremental growth aligned to 6–8% EPS targets.

Management priorities

  • Complete remaining FY26 capital projects to reach $4.2 billion in full-year capex.
  • Implement the $155–$165 million pretax benefit from final Texas Rule 7.7102 rulemaking.
  • Advance 13 regulatory filings targeting nearly $600 million of annualized operating-income increases, with ~40% expected in Q3.
  • Grow APT through-system business by an additional $0.08–$0.12 in H2 FY26.
  • Maintain incremental dividend growth consistent with 6–8% EPS growth targets.

Related earnings events

Utilities

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-07-30T12:41:07.621277+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T12:41:07.618386+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.